Old Web
English
Sign In
Acemap
>
authorDetail
>
Klaus Maria Josten
Klaus Maria Josten
Praxis
Rash
FOLFIRI
Cetuximab
Doxycycline
Colorectal cancer
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first-line metastatic colorectal cancer receiving a pre-defined skin care
2017
Journal of Cancer Research and Clinical Oncology
Carl C. Schimanski
Frank Staib
Thomas Göhler
Holger Hebart
M Heike
Michael Neise
Jochen Rudi
Thomas Geer
Gerrit Dingeldein
Claudia Lang
Peter Ehscheidt
Thomas Flohr
Klaus Maria Josten
Meinolf Karthaus
Alexander Schmittel
Jan Wierecky
Emil Boller
Martin Indorf
Marcus-Alexander Wörns
Peter R. Galle
Markus Moehler
Show All
Source
Cite
Save
Citations (1)
A nonrandomized, phase IV trial of FOLFIRI and cetuximab in first-line treatment of metastatic colorectal cancer receiving a predefined skin care and skin prophylaxis aiming to prevent a skin rash.
2014
Journal of Clinical Oncology
Thomas Goehler
M. Woerns
Holger Hebart
M Heike
Michael Neise
Jochen Rudi
Thomas Geer
Gerrit Dingeldein
Claudia Lang
Peter Ehscheidt
Thomas Flohr
Klaus Maria Josten
Meinolf Karthaus
Alexander Schmittel
Jan Wierecky
Peter R. Galle
Carmen Dhensaw
Markus Moehler
Carl C. Schimanski
Show All
Source
Cite
Save
Citations (0)
1